{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:08:14Z","timestamp":1777633694483,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.nec.2009.08.005","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T02:42:04Z","timestamp":1259376124000},"page":"31-42","source":"Crossref","is-referenced-by-count":84,"title":["Glioblastoma-Derived Mechanisms of Systemic Immunosuppression"],"prefix":"10.1016","volume":"21","author":[{"given":"Allen","family":"Waziri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib1","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.136.6.1631","article-title":"Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor","volume":"136","author":"Brooks","year":"1972","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib2","first-page":"419","article-title":"Immune responses in patients with gliomas","volume":"2","author":"Brooks","year":"1974","journal-title":"Surg Neurol"},{"issue":"1-2","key":"10.1016\/j.nec.2009.08.005_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0165-5728(99)00203-9","article-title":"Immune defects observed in patients with primary malignant brain tumors","volume":"100","author":"Dix","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"14","key":"10.1016\/j.nec.2009.08.005_bib4","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1158\/0008-5472.CAN-07-5973","article-title":"Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients","volume":"68","author":"Wheeler","year":"2008","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.nec.2009.08.005_bib5","first-page":"93","article-title":"The biology of malignant gliomas\u2013a comprehensive survey","volume":"3","author":"McComb","year":"1984","journal-title":"Clin Neuropathol"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1158\/1541-7786.MCR-07-0280","article-title":"Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas","volume":"6","author":"Li","year":"2008","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/clim.2001.5152","article-title":"Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro","volume":"102","author":"Anderson","year":"2002","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1227\/01.neu.0000316019.28421.95","article-title":"Identification of A2B5+CD133\u2212 tumor-initiating cells in adult human gliomas","volume":"62","author":"Ogden","year":"2008","journal-title":"Neurosurgery"},{"issue":"7015","key":"10.1016\/j.nec.2009.08.005_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1005805203044","article-title":"Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas","volume":"36","author":"Barth","year":"1998","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.nec.2009.08.005_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00006123-200010000-00050","article-title":"Limitations of the C6\/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy","volume":"47","author":"Parsa","year":"2000","journal-title":"Neurosurgery"},{"issue":"1-2","key":"10.1016\/j.nec.2009.08.005_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1006462504447","article-title":"Models for assessment of angiogenesis in gliomas","volume":"50","author":"Goldbrunner","year":"2000","journal-title":"J Neurooncol"},{"issue":"25","key":"10.1016\/j.nec.2009.08.005_bib13","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1523\/JNEUROSCI.0514-06.2006","article-title":"Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses","volume":"26","author":"Assanah","year":"2006","journal-title":"J Neurosci"},{"issue":"14","key":"10.1016\/j.nec.2009.08.005_bib14","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1158\/0008-5472.CAN-03-3831","article-title":"Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis","volume":"64","author":"Shih","year":"2004","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.nec.2009.08.005_bib15","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.4049\/jimmunol.180.11.7673","article-title":"Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma","volume":"180","author":"Waziri","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.nec.2009.08.005_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2172-10-11","article-title":"Dynamics of central and peripheral immunomodulation in a murine glioma model","volume":"10","author":"Kennedy","year":"2009","journal-title":"BMC Immunol"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-007-9400-9","article-title":"Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression","volume":"85","author":"Candolfi","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.nec.2009.08.005_bib18","first-page":"12","article-title":"Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human glioma","volume":"7","author":"Dunn","year":"2007","journal-title":"Cancer Immun"},{"issue":"1-2","key":"10.1016\/j.nec.2009.08.005_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02700020","article-title":"Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium","volume":"64","author":"Yu","year":"2003","journal-title":"J Neurooncol"},{"issue":"8","key":"10.1016\/j.nec.2009.08.005_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/intimm\/11.8.1337","article-title":"Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset","volume":"11","author":"Perrin","year":"1999","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-2478(93)90164-W","article-title":"Skewed distribution of TCR V alpha 7-bearing T cells within tumor-infiltrating lymphocytes of HLA-A24(9)-positive patients with malignant glioma","volume":"39","author":"Ebato","year":"1993","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/039463200401700108","article-title":"T\u00a0lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors","volume":"17","author":"Kempuraj","year":"2004","journal-title":"Int J\u00a0Immunopathol Pharmacol"},{"issue":"9","key":"10.1016\/j.nec.2009.08.005_bib23","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.159.9.4415","article-title":"T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors","volume":"159","author":"Morford","year":"1997","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.nec.2009.08.005_bib25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3171\/jns.2002.96.3.0580","article-title":"Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism","volume":"96","author":"Didenko","year":"2002","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02478923","article-title":"Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors","volume":"18","author":"Ichinose","year":"2001","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"10.1016\/j.nec.2009.08.005_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s004010050799","article-title":"Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines","volume":"95","author":"Husain","year":"1998","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI119273","article-title":"Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?","volume":"99","author":"Saas","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1006473800589","article-title":"Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion","volume":"48","author":"Frankel","year":"2000","journal-title":"J Neurooncol"},{"key":"10.1016\/j.nec.2009.08.005_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.1998.tb01192.x","article-title":"Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G","volume":"163","author":"O'Callaghan","year":"1998","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.nec.2009.08.005_bib31","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.168.9.4772","article-title":"A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape","volume":"168","author":"Wiendl","year":"2002","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.nec.2009.08.005_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1044-579X(03)00028-2","article-title":"Secretion of sHLA-G molecules in malignancies","volume":"13","author":"Rebmann","year":"2003","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jnen\/64.6.523","article-title":"HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo","volume":"64","author":"Wischhusen","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1-2","key":"10.1016\/j.nec.2009.08.005_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2007.07.002","article-title":"Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells","volume":"189","author":"Mittelbronn","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nec.2009.08.005_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"21","key":"10.1016\/j.nec.2009.08.005_bib36","first-page":"7462","article-title":"Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis","volume":"63","author":"Wintterle","year":"2003","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.nec.2009.08.005_bib37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/00001756-200507130-00010","article-title":"B7-homolog 1 expression by human glioma: a new mechanism of immune evasion","volume":"16","author":"Wilmotte","year":"2005","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm1517","article-title":"Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma","volume":"13","author":"Parsa","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.nec.2009.08.005_bib39","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.132.4.1837","article-title":"Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects","volume":"132","author":"Fontana","year":"1984","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.4049\/jimmunol.134.2.1003","article-title":"Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells","volume":"134","author":"Schwyzer","year":"1985","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib41","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/j.1460-2075.1987.tb02411.x","article-title":"T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta","volume":"6","author":"Wrann","year":"1987","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib42","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3171\/jns.1987.67.6.0874","article-title":"Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor","volume":"67","author":"Roszman","year":"1987","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.nec.2009.08.005_bib43","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ijc.2910420416","article-title":"The glioblastoma-derived T-cell suppressor factor\/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells","volume":"42","author":"Kuppner","year":"1988","journal-title":"Int J\u00a0Cancer"},{"issue":"10","key":"10.1016\/j.nec.2009.08.005_bib44","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.4049\/jimmunol.143.10.3222","article-title":"Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2","volume":"143","author":"Bodmer","year":"1989","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.nec.2009.08.005_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ijc.2910620405","article-title":"Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma","volume":"62","author":"Yamada","year":"1995","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.nec.2009.08.005_bib46","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.4049\/jimmunol.148.5.1404","article-title":"Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia","volume":"148","author":"Constam","year":"1992","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.nec.2009.08.005_bib47","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0046-8177(92)90297-G","article-title":"Distribution of transforming growth factor-beta 1 in human astrocytomas","volume":"23","author":"Horst","year":"1992","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.nec.2009.08.005_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1179\/016164107X235149","article-title":"Decreased levels of interleukin-10 and transforming growth factor-beta 2 in cerebrospinal fluid of patients with high grade astrocytoma","volume":"30","author":"Krzyszkowski","year":"2008","journal-title":"Neurol Res"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-5728(97)00236-1","article-title":"Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: effect of tumor extirpation","volume":"84","author":"Woiciechowsky","year":"1998","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jcp.57.1.6","article-title":"The eicosanoid cascade: possible role in gliomas and meningiomas","volume":"57","author":"Nathoo","year":"2004","journal-title":"J Clin Pathol"},{"issue":"3-4","key":"10.1016\/j.nec.2009.08.005_bib51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00688305","article-title":"Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells","volume":"69","author":"Lauro","year":"1986","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-5728(91)90052-9","article-title":"Malignant glioma modulation of immune function: relative contribution of different soluble factors","volume":"33","author":"Couldwell","year":"1991","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10.1016\/j.nec.2009.08.005_bib53","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.4049\/jimmunol.173.7.4352","article-title":"Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma","volume":"173","author":"Akasaki","year":"2004","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.nec.2009.08.005_bib54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(94)91055-3","article-title":"Selective expression of interleukin-10 gene within glioblastoma multiforme","volume":"649","author":"Nitta","year":"1994","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib55","first-page":"317","article-title":"Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas","volume":"146","author":"Huettner","year":"1995","journal-title":"Am J Pathol"},{"issue":"5A","key":"10.1016\/j.nec.2009.08.005_bib56","first-page":"3217","article-title":"Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro","volume":"17","author":"Huettner","year":"1997","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O","article-title":"Microglial\/macrophage expression of interleukin 10 in human glioblastomas","volume":"82","author":"Wagner","year":"1999","journal-title":"Int J Cancer"},{"issue":"1-2","key":"10.1016\/j.nec.2009.08.005_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11010-007-9517-3","article-title":"Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors","volume":"304","author":"Samaras","year":"2007","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1227\/00006123-198202000-00006","article-title":"Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas","volume":"10","author":"Braun","year":"1982","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00182953","article-title":"Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells","volume":"1","author":"Wood","year":"1983","journal-title":"J Neurooncol"},{"issue":"8","key":"10.1016\/j.nec.2009.08.005_bib61","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.4049\/jimmunol.162.8.4882","article-title":"Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers","volume":"162","author":"Zou","year":"1999","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.nec.2009.08.005_bib62","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.4049\/jimmunol.181.8.5425","article-title":"Astrocytic regulation of human monocytic\/microglial activation","volume":"181","author":"Kostianovsky","year":"2008","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.nec.2009.08.005_bib63","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.nec.2009.08.005_bib64","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1227\/01.NEU.0000233907.03070.7B","article-title":"Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas","volume":"59","author":"Ogden","year":"2006","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3171\/jns.2006.105.1.41","article-title":"Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy","volume":"105","author":"Rapp","year":"2006","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/smim.1999.0168","article-title":"Leukocyte traffic in the central nervous system: the participants and their roles","volume":"11","author":"Hickey","year":"1999","journal-title":"Semin Immunol"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3171\/jns.1987.67.2.0231","article-title":"Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas","volume":"67","author":"Elliott","year":"1987","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2009.08.005_bib68","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcancer.2005.11.003","article-title":"Regulatory cells and human cancer","volume":"16","author":"Baecher-Allan","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.nec.2009.08.005_bib69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-065X.2008.00637.x","article-title":"Human regulatory T cells: role in autoimmune disease and therapeutic opportunities","volume":"223","author":"Brusko","year":"2008","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.nec.2009.08.005_bib70","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.nec.2009.08.005_bib71","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity","volume":"163","author":"Shimizu","year":"1999","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.nec.2009.08.005_bib72","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","article-title":"Natural regulatory T cells in infectious disease","volume":"6","author":"Belkaid","year":"2005","journal-title":"Nat Immunol"},{"issue":"1-2","key":"10.1016\/j.nec.2009.08.005_bib73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11302-006-9050-y","article-title":"CD39 and control of cellular immune responses","volume":"3","author":"Dwyer","year":"2007","journal-title":"Purinergic Signal"},{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib74","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1158\/0008-5472.CAN-05-3773","article-title":"Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma","volume":"66","author":"Fecci","year":"2006","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.nec.2009.08.005_bib75","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1215\/15228517-2006-006","article-title":"An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme","volume":"8","author":"El Andaloussi","year":"2006","journal-title":"Neuro Oncol"},{"issue":"16","key":"10.1016\/j.nec.2009.08.005_bib76","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1158\/1078-0432.CCR-08-0320","article-title":"Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas","volume":"14","author":"Heimberger","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.nec.2009.08.005_bib77","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-07-5664","article-title":"The regulatory T\u00a0cell-associated transcription factor FoxP3 is expressed by tumor cells","volume":"68","author":"Ebert","year":"2008","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib78","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.180.6.3627","article-title":"NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis","volume":"180","author":"Berzofsky","year":"2008","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.nec.2009.08.005_bib79","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/82782","article-title":"Immune suppression and skin cancer development: regulation by NKT cells","volume":"1","author":"Moodycliffe","year":"2000","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.nec.2009.08.005_bib80","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ijc.20669","article-title":"Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13","volume":"114","author":"Park","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nec.2009.08.005_bib81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-230X(08)00408-9","article-title":"The role of NKT cells in tumor immunity","volume":"101","author":"Terabe","year":"2008","journal-title":"Adv Cancer Res"},{"issue":"11","key":"10.1016\/j.nec.2009.08.005_bib82","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20022227","article-title":"Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence","volume":"198","author":"Terabe","year":"2003","journal-title":"J Exp Med"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368009000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368009000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T18:02:08Z","timestamp":1685210528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368009000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1042368009000758"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2009.08.005","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}